-
公开(公告)号:WO2023028254A2
公开(公告)日:2023-03-02
申请号:PCT/US2022/041561
申请日:2022-08-25
发明人: REX, Tonia S. , BACKSTROM, Jon R.
IPC分类号: C12N15/09 , C12N15/11 , C12N15/63 , C12N15/79 , C12N15/85 , C12N15/86 , C12N15/87 , C12N15/90 , A61K48/00 , C12N15/00 , C12N15/102 , C12N15/635 , C12N2310/20 , C12N2750/14143
摘要: The presently-disclosed subject matter relates to a compositions and methods that makes use of a CasΦ(CasPhi) that has been modified for effective nuclear targeting. In particular, certain embodiments of the presently-disclosed subject matter relate to unique nucleic acid molecules, compositions, and methods for delivery of CasPhi to the nucleus to effectively modulate expression or otherwise target of a gene of interest. A nucleic acid disclosed herein includes a nucleotide encoding a CasPhi, wherein there are no amino acid substitutions, or wherein proline residues at amino acids 749 and 753 have been substituted; a nucleotide encoding an amino-terminal linker connected to the amino-terminal end of the CasPhi; a nucleotide encoding a carboxy -terminal linker connected to the carboxy-terminal end of the CasPhi; and a nucleotide encoding a nuclear localization signal (NLS) downstream from the CasPhi and carboxy-terminal linker.
-
公开(公告)号:WO2023016978A1
公开(公告)日:2023-02-16
申请号:PCT/EP2022/072214
申请日:2022-08-08
发明人: MILLEN, Anne M. , ROMERO, Dennis , SIMDON, Laura
IPC分类号: C07K14/195 , C12N15/74 , C12N15/10 , C12N15/102 , C12N15/746 , C12N2310/20 , C12N9/22 , C12R2001/46
摘要: Provided herein are compositions for enabling natural adaptive spacer acquisition in CRISPR-Cas systems incapable of adaptation, e.g., non-adapting lactococcal CRISPR-Cas systems. Also provided are methods for using the compositions and products thereof to produce bacterial strains that are resistant, such as bacteriophage resistant, and/or evolved to have a desirable phenotype. Non-adapting CRISPR-Cas systems adapted according to the methods provided herein, and bacteria containing such adapted non-adapting CRISPR-Cas systems, are further provided. The compositions and methods provided herein allow for the controlled induction of natural spacer acquisition via adaptation in CRISPR-Cas systems that are fundamentally incapable of adaptation without modifying the features underlying the non-adapting behavior of the CRISPR-Cas system.
-
公开(公告)号:WO2022269037A1
公开(公告)日:2022-12-29
申请号:PCT/EP2022/067351
申请日:2022-06-24
申请人: QUIDDITAS SA
IPC分类号: C12N15/10 , C12N15/90 , C12N15/102 , C12N15/907
摘要: L'invention concerne un complexe moléculaire comprenant - une première molécule d'acides nucléiques simple brin comprenant au moins deux demi-sites de liaison d'une transposase, et - une deuxième molécule d'acides nucléiques simple brin au moins un demi-site de liaison d'une transposase, ledit complexe étant tel que les première et deuxième molécules d'acides nucléiques simple brin sont appariées selon la complémentarité des bases définie par Watson et Crick de sorte à définir deux sites double brin de liaison de ladite transposase. L'invention concerne par ailleurs l'utilisation de ce complexe, en particulier pour l'édition de l'ADN.
-
公开(公告)号:WO2022240262A1
公开(公告)日:2022-11-17
申请号:PCT/KR2022/006940
申请日:2022-05-13
IPC分类号: C12N15/10 , C12N15/113 , C12N9/22 , C12N15/63 , A61K31/7088 , A61K48/00 , C12N15/102 , C12N2310/20
摘要: 본 발명은 CRISPR/Cas12f1(Cas14a1) system을 이용한 LCA10 질환 치료에 관한 것이다. 보다 구체적으로, 본 발명은 LCA10 질환 치료를 위한 CRISPR/Cas12f1(Cas14a1) system을 포함하는 조성물 및 이를 이용한 치료 방법에 관한 것이다. 또한, 본 발명은 CEP290 유전자를 인위적으로 조작하기 위한 CRISPR/Cas12f1(Cas14a1) system을 포함하는 조성물 및 이를 이용한 CEP290 유전자의 조작 방법에 관한 것이다.
-
公开(公告)号:WO2022170199A2
公开(公告)日:2022-08-11
申请号:PCT/US2022/015504
申请日:2022-02-07
申请人: EMENDOBIO INC. , IZHAR, Lior , ROCKAH, Liat , MARBACH BAR, Nadav , HECHT, Nir
发明人: IZHAR, Lior , ROCKAH, Liat , MARBACH BAR, Nadav , HECHT, Nir
IPC分类号: A61K38/46 , A61K48/00 , C12N9/22 , C12N15/11 , C12N15/102 , C12N2310/20
摘要: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
-
公开(公告)号:WO2022094323A8
公开(公告)日:2022-05-05
申请号:PCT/US2021/057426
申请日:2021-10-29
发明人: WESSELLS, Quinton, Norman , HASWELL, Jeffrey, Raymond , DITOMMASO, Tia, Marie , JAKIMO, Noah, Michael
IPC分类号: C12N15/113 , C12N15/10 , C12N9/22 , A61K31/7088 , C12N15/102 , C12N2310/20
摘要: The present invention relates to compositions comprising RNA guides targeting BCL11A, processes for characterizing the compositions, cells comprising the compositions, and methods of using the compositions.
-
公开(公告)号:WO2022051020A2
公开(公告)日:2022-03-10
申请号:PCT/US2021/040160
申请日:2021-07-01
IPC分类号: C12N9/22 , C12N9/50 , C12N15/10 , A61K38/00 , C12N15/102 , C12N15/11 , C12N2310/20 , C12N2320/33 , C12N9/78 , C12Y305/04004 , C12Y305/04005
摘要: This disclosure provides systems, methods, and compositions for RNA-guided RNA- targeting CRISPR effectors for the treatment of diseases as well as diagnostics. In some embodiments, nucleotide deaminase functionalized CRISPR systems for RNA editing RNA knockdown, viral resistance, splicing modulation, RNA tracking, translation modulation, and epi-transcriptomic modifications are disclosed.
-
公开(公告)号:WO2021195458A1
公开(公告)日:2021-09-30
申请号:PCT/US2021/024283
申请日:2021-03-26
IPC分类号: C07K14/415 , C12N15/82 , A01H6/4684 , C12N15/102 , C12N15/113 , C12N15/8213 , C12N15/8261 , C12N2310/20 , C12N9/22
摘要: This invention relates to compositions and methods for modifying FACIATED EAR2 (FEA2) genes in plants, optionally to modify meristem size. The invention further relates to plants having increased kernel row number produced using the methods and compositions of the invention.
-
公开(公告)号:WO2021195456A1
公开(公告)日:2021-09-30
申请号:PCT/US2021/024281
申请日:2021-03-26
发明人: MILLER, Marisa
IPC分类号: C07K14/415 , C12N9/22 , C12N15/82 , A01H6/542 , C12N15/102 , C12N15/113 , C12N15/8213 , C12N15/8279 , C12N2310/20
摘要: This invention relates to compositions and methods for modifying STAYGREEN (SGR) genes in plants. The invention further relates to plants produced using the methods and compositions of the invention comprising modified endogenous SGR genes and having increased resistance to soybean rust.
-
公开(公告)号:WO2021178432A1
公开(公告)日:2021-09-10
申请号:PCT/US2021/020513
申请日:2021-03-02
发明人: CONG, Le
IPC分类号: C07K14/195 , C07K19/00 , C12N9/22 , C12N9/78 , C12N15/113 , C12N15/63 , C12N15/102 , C12N2310/20
摘要: The present disclosure provides recombineering-editing systems using CRISPR and recombination enzymes as well as methods, vectors, nucleic acid compositions, and kits thereof. The methods and systems provide means for altering target DNA, including genomic DNA in a host cell.
-
-
-
-
-
-
-
-
-